Medigene AG (FRA:MDG1) Short-Term Capital Lease Obligation : €0.91 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Medigene AG Short-Term Capital Lease Obligation?

Medigene AG's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.91 Mil.

Medigene AG's quarterly Short-Term Capital Lease Obligation declined from Dec. 2022 (€0.98 Mil) to Jun. 2023 (€0.91 Mil) but then increased from Jun. 2023 (€0.91 Mil) to Dec. 2023 (€0.91 Mil).

Medigene AG's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€0.89 Mil) to Dec. 2022 (€0.98 Mil) but then declined from Dec. 2022 (€0.98 Mil) to Dec. 2023 (€0.91 Mil).

Medigene AG Short-Term Capital Lease Obligation Historical Data

The historical data trend for Medigene AG's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Short-Term Capital Lease Obligation Chart

Medigene AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.07

1.16

0.89

0.98

0.91

Medigene AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.89	0.73	0.98	0.91	0.91

Medigene AG Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Medigene AG Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Medigene AG's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigene AG (FRA:MDG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (FRA:MDG1) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

MDGEF:USA MDG1:Germany MDG1:Austria

Address

Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.medigene.com

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (FRA:MDG1) Headlines

No Headlines